HCAT
Health Catalyst Inc
$3.39
-$0.26(-7.12%)
47
Overall
--
Value
40
Tech
55
Quality
Market Cap
$246.31M
Volume
985.74K
52W Range
$2.52 - $9.24
Target Price
$5.00
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | $154.9M | $188.8M | $241.9M | $276.2M | $295.9M | $306.6M | ||
| Total Revenue | $154.9M | $188.8M | $241.9M | $276.2M | $295.9M | $306.6M | ||
| COST OF GOODS SOLD | ||||||||
| Cost of Revenue | $75.3M | $98.1M | $124.4M | $143.0M | $164.1M | $165.8M | ||
| GROSS PROFIT | ||||||||
| Gross Profit | $79.6M | $90.8M | $117.6M | $133.2M | $131.8M | $140.8M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $134.5M | $186.9M | $261.2M | $273.2M | $258.7M | $210.6M | ||
| Research & Development | $46.3M | $53.5M | $62.7M | $75.7M | $72.6M | $58.0M | ||
| Research Expense | $46.3M | $53.5M | $62.7M | $75.7M | $72.6M | $58.0M | ||
| Selling, General & Administrative | $79.0M | $114.7M | $161.0M | $149.2M | $143.9M | $111.2M | ||
| Selling & Marketing Expenses | $47.3M | $55.4M | $75.0M | $87.5M | $67.3M | $54.4M | ||
| General & Administrative Expenses | $31.7M | $59.2M | $85.9M | $61.7M | $76.6M | $56.8M | ||
| Promotion & Advertising | $4.9M | $4.3M | $4.4M | -- | -- | -- | ||
| Salaries & Wages | -- | -- | -- | $72.1M | $55.8M | $40.1M | ||
| Depreciation & Amortization | $9.2M | $18.7M | $37.5M | $48.3M | $42.2M | $41.4M | ||
| Depreciation & Amortization | $9.2M | $18.7M | $37.5M | $48.3M | $42.2M | $41.4M | ||
| Amortization | $7.4M | $115.9M | $181.9M | $188.1M | $193.0M | $263.0M | ||
| Other Operating Expenses | $-401.0K | $-1.5M | $-1.4M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||
| Operating income | $-54.9M | $-96.1M | $-143.7M | $-140.0M | $-126.9M | $-69.8M | ||
| EBITDA | $-46.9M | $-85.9M | $-106.1M | $-84.6M | $-74.1M | $-24.5M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | -- | $11.6M | $17.3M | $7.2M | $7.3M | -- | ||
| Intinc | -- | -- | -- | -- | $9.1M | $637.0K | ||
| Net Non-Operating Interest Income/Expense | -- | -- | -- | $1.6M | $9.1M | $637.0K | ||
| Other Income/Expense | $1.7M | $8.5M | $99.0K | $-126.0K | $4.0K | -- | ||
| Other Special Charges | $-1.7M | $-8.5M | -- | -- | -- | -- | ||
| SPECIAL ITEMS | ||||||||
| Restructring And Mn A Income | $90.8M | $124.5M | -- | -- | -- | -- | ||
| Special Income Charges | $-90.8M | $-124.5M | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-56.5M | $-104.6M | $-143.7M | $-134.4M | $-117.8M | $-69.2M | ||
| Pre-Tax Income | $-56.5M | $-104.6M | $-143.7M | $-141.7M | $-117.8M | $-69.2M | ||
| INCOME TAX | ||||||||
| Tax Provision | $142.0K | $-1.2M | $-6.9M | $-4.3M | $356.0K | $333.0K | ||
| NET INCOME | ||||||||
| Net Income | $-60.1M | $-115.0M | $-153.2M | $-137.4M | $-118.1M | $-69.5M | ||
| Net Income (Continuing Operations) | $-60.1M | $-115.0M | $-153.2M | $-137.4M | $-118.1M | $-69.5M | ||
| Net Income (Discontinued Operations) | $-60.1M | $-115.0M | $-153.2M | $-137.4M | $-118.1M | $-69.5M | ||
| Net Income (Common Stockholders) | $-240.9M | $-115.0M | $-153.2M | $-137.4M | $-118.1M | $-69.5M | ||
| TOTALS | ||||||||
| Total Expenses | $209.8M | $285.0M | $385.6M | $416.2M | $422.8M | $376.4M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $18.7M | $39.5M | $47.5M | $53.7M | $56.4M | $60.2M | ||
| Average Shares Outstanding (Diluted) | $18.7M | -- | $47.5M | $54.1M | $56.4M | $60.2M | ||
| Shares Outstanding | $37.3M | $44.0M | $53.3M | $55.8M | $58.6M | $70.2M | ||
| Basic EPS | $-12.86 | $-2.91 | $-3.23 | $-2.56 | $-2.09 | $-1.15 | ||
| Basic EPS (Continuing Operations) | $-12.86 | $-2.91 | $-3.23 | $-2.56 | $-2.09 | $-1.15 | ||
| Diluted EPS | $-12.86 | $-2.91 | $-3.23 | $-2.63 | $-2.09 | $-1.15 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-3.23 | $-2.63 | $-2.09 | $-1.15 | ||
| OTHER METRICS | ||||||||
| Accretion On Preferred Stock | $180.8M | -- | -- | -- | -- | -- | ||
| Acquisition Expense | -- | $2.7M | $1.4M | $2.3M | $3.5M | $8.0M | ||
| Other Gand A | $31.7M | $59.2M | $85.9M | $61.7M | $76.6M | $56.8M | ||
| Other Write Off | -- | $197.0K | $99.0K | -- | -- | -- | ||
| Otherunder Preferred Stock Dividend | $180.8M | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $180.8M | -- | -- | -- | -- | -- | ||
| Restruct | $90.8M | $124.5M | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HCAT | $3.39 | -7.1% | 985.74K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |